Cargando…
Prevalence and treatment of patients with eating disorders: Data of a german health insurance
INTRODUCTION: Few studies have examined the course of eating disorders and the respective treatments based on insurance data, even though they provide representative information. OBJECTIVES: To assess the epidemiology, treatments, duration of illness, costs of treatment in a data set of a public hea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470461/ http://dx.doi.org/10.1192/j.eurpsy.2021.324 |
_version_ | 1784788849712431104 |
---|---|
author | Herrmann, K. Kaluscha, R. Liebert, A. Wietersheim, J. Von |
author_facet | Herrmann, K. Kaluscha, R. Liebert, A. Wietersheim, J. Von |
author_sort | Herrmann, K. |
collection | PubMed |
description | INTRODUCTION: Few studies have examined the course of eating disorders and the respective treatments based on insurance data, even though they provide representative information. OBJECTIVES: To assess the epidemiology, treatments, duration of illness, costs of treatment in a data set of a public health insurance. METHODS: Data provided by a German health insurance (data from 4.2 million members from 2005-2010). A matched control group based on age and gender without an eating disorder diagnosis was used for comparisons. RESULTS: 2.734 cases with the diagnoses of an eating disorder (anorexia nervosa AN, bulimia nervosa BN or combination ANBN) were identified. More than 92% of the patients were female. The relative risk for personality disorders, depressive disorders, alcohol abuse and obsessive-compulsive disorders was highly increased. Most of the patients with BN (53.04%) or AN (41.57%) were treated in out-patient care, and many were only treated for three months, whereas most of the patients with ANBN were treated for a longer time. 3-19% with BN, AN or ANBN were treated only in in-patient care. The in-patient costs of treatment for the year of the diagnosis were 5471.15€ for BN, 9080.26€ for AN, 10809.16€ for ANBN and 339.37€ for the control group. CONCLUSIONS: Our findings suggest that patients with ANBN diagnosis have a severe and longer course of treatment. Furthermore, contrary to national guidelines for eating disorders, there is a considerable proportion of patients with BN or AN that are treated only in in-patient care. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9470461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94704612022-09-29 Prevalence and treatment of patients with eating disorders: Data of a german health insurance Herrmann, K. Kaluscha, R. Liebert, A. Wietersheim, J. Von Eur Psychiatry Abstract INTRODUCTION: Few studies have examined the course of eating disorders and the respective treatments based on insurance data, even though they provide representative information. OBJECTIVES: To assess the epidemiology, treatments, duration of illness, costs of treatment in a data set of a public health insurance. METHODS: Data provided by a German health insurance (data from 4.2 million members from 2005-2010). A matched control group based on age and gender without an eating disorder diagnosis was used for comparisons. RESULTS: 2.734 cases with the diagnoses of an eating disorder (anorexia nervosa AN, bulimia nervosa BN or combination ANBN) were identified. More than 92% of the patients were female. The relative risk for personality disorders, depressive disorders, alcohol abuse and obsessive-compulsive disorders was highly increased. Most of the patients with BN (53.04%) or AN (41.57%) were treated in out-patient care, and many were only treated for three months, whereas most of the patients with ANBN were treated for a longer time. 3-19% with BN, AN or ANBN were treated only in in-patient care. The in-patient costs of treatment for the year of the diagnosis were 5471.15€ for BN, 9080.26€ for AN, 10809.16€ for ANBN and 339.37€ for the control group. CONCLUSIONS: Our findings suggest that patients with ANBN diagnosis have a severe and longer course of treatment. Furthermore, contrary to national guidelines for eating disorders, there is a considerable proportion of patients with BN or AN that are treated only in in-patient care. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9470461/ http://dx.doi.org/10.1192/j.eurpsy.2021.324 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Herrmann, K. Kaluscha, R. Liebert, A. Wietersheim, J. Von Prevalence and treatment of patients with eating disorders: Data of a german health insurance |
title | Prevalence and treatment of patients with eating disorders: Data of a german health insurance |
title_full | Prevalence and treatment of patients with eating disorders: Data of a german health insurance |
title_fullStr | Prevalence and treatment of patients with eating disorders: Data of a german health insurance |
title_full_unstemmed | Prevalence and treatment of patients with eating disorders: Data of a german health insurance |
title_short | Prevalence and treatment of patients with eating disorders: Data of a german health insurance |
title_sort | prevalence and treatment of patients with eating disorders: data of a german health insurance |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470461/ http://dx.doi.org/10.1192/j.eurpsy.2021.324 |
work_keys_str_mv | AT herrmannk prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance AT kaluschar prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance AT lieberta prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance AT wietersheimjvon prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance |